Zyomyx Closes $10M Funding, Bringing its VC Support to over $100 Million in Six Years | GenomeWeb

Last week, Hayward, Calif.-based Zyomyx announced the closing of a $10 million funding round as it prepares for a planned launch of a second line of biochips in April.

The funding comes at a time when it appears the venture-capital market is ending a period of investment retreat; Wall Street appears to be more open to initial public offerings; and investors are driving up the shares of many biotech-related stocks.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.